Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=25475106
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
What is your reasonable expectation of success in obtaining pharmaceutical or
biotechnology patents having nonobvious claimed inventions that the courts will
uphold? An overview of obviousness court decisions
#MMPMID25475106
Pereira DJ
; Kunin SG
Cold Spring Harb Perspect Med
2014[Dec]; 5
(4
): ? PMID25475106
show ga
This article explores the legal basis for establishing the nonobviousness of
patent claims in the life sciences fields of technology drawn from the guidance
provided in published decisions of the U.S. Patent and Trademark Office's Patent
Trial and Appeal Board, federal district courts, the Federal Circuit Court of
Appeals, and the U.S. Supreme Court. Our analysis, although equally applicable to
all disciplines and technologies, focuses primarily on decisions of greatest
import affecting patents in the fields of pharmaceutical chemistry and
biotechnology.